Navigation Links
Scientists ID Likely Culprit in 'Popcorn Lung'

Dutch team zeroes in on diacetyl, a key component of butter flavoring in microwave brands

SATURDAY, Sept. 1 (HealthDay News) -- A key chemical ingredient in the buttery flavoring of microwave popcorn has been identified as a likely culprit in "popcorn lung," a lung disease that afflicts people who work in the microwave popcorn manufacturing industry, Dutch researchers report.

Publishing in the September issue of the American Journal of Respiratory and Critical Care Medicine, the team said that the chemical diacetyl may be responsible for more cases of bronchiolitis obliterans syndrome (BOS), otherwise known as "popcorn lung," at a diacetyl factory.

"Our study found a cluster of [previously undiagnosed] BOS cases in a diacetyl production plant," lead author Dr. Frits van Rooy, of the Division of Environmental Epidemiology at the Universiteit Utrecht, said in a prepared statement. "This supports the conclusion that an agent in the diacetyl production process has caused BOS."

The disease was first noticed in 2001 among workers at an American plant that made microwaveable popcorn. Diacetyl was identified early on as an indicator of exposure, but the chemical's role in the development of the lung disease was not known.

The research team in the Netherlands traced 196 former workers who were still alive and had been employed at the diacetyl production plant between 1960 and 2003. They identified 175 who agreed to fill out exposure and respiratory health questionnaires. The workers also took lung function tests and completed clinical assessments. Four cases of "popcorn lung" were identified in the 102 workers thought to be at risk for high exposure.

The authors noted that this was the first study of lung health among workers for a plant producing diacetyl. They acknowledged that they could not rule out the impact of other chemicals made at the same plant, but the data created a stronger case for diacetyl as a possible cause of "popcorn lung." Acetoin and acetyldehyde may also contribute, the researchers said.

An editorial accompanying the journal article expressed concern over the fact that none of the four cases had been diagnosed as an occupationally related lung disease or bronchiolitis obliterans specifically prior to the study.

More information

To learn more about bronchiolitis obliterans, visit Haz-Map: Occupational Exposure to Hazardous Agents.

-- Madeline Vann

SOURCE: American Thoracic Society, news release, Sept. 1, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack dengue fever puzzle
4. Scientists found ancient Human Germ Killer
5. Scientists locate key hormone involved in appetite control
6. Scientists open the book of life
7. Electronic nose by Italian scientists
8. Scientists review SARS
9. Scientists push to lower hidden sodium in food
10. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
11. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: